Letaief Ksontini Feryel, Khrouf Salim, Kacem Selma, Haddad Anis, Magherbi Houcine, Chaker Youssef, Ayadi Mouna, Ben Safta Zoubair
Medical Oncology Department, Salah Azaiz Institute, 1002 Bab Saadoun, Tunis, Tunisia.
Surgical Oncology Department, Salah Azaiz Institute, 1002 Bab Saadoun, Tunis, Tunisia.
Case Rep Med. 2021 Mar 6;2021:5579385. doi: 10.1155/2021/5579385. eCollection 2021.
Pancreatic metastasis (PM) of renal cancer is a rare condition. It is characterized by a long period after initial nephrectomy and a favorable prognosis compared to other pancreatic malignancies. Its diagnosis may confuse clinicians if the medical history is not known. In the era of targeted therapies for metastatic renal carcinoma, surgery stands as the best treatment option for PM of renal cancer. We report the case of a woman who underwent successfully left splenopancreatectomy for corporeal PM of renal cancer treated seven years ago. This case underlines the necessity of long-term follow-up of patients treated for kidney cancer.
肾癌的胰腺转移（PM）是一种罕见情况。其特点是在初次肾切除术后有较长时间，且与其他胰腺恶性肿瘤相比预后较好。如果病史不明，其诊断可能会使临床医生感到困惑。在转移性肾癌的靶向治疗时代，手术是肾癌胰腺转移的最佳治疗选择。我们报告一例七年前接受治疗的肾癌实体性胰腺转移患者成功接受左脾胰切除术的病例。该病例强调了对接受肾癌治疗患者进行长期随访的必要性。
